Legislation recently introduced in the U.S. House of Representatives aims to prevent opioid addiction in patients.
The Opioid Patients’ Right to Know Act would establish a grant program for states. To receive the grant, states must require prescribers to inform patients of alternative options before prescribing treatment for acute pain and discuss the addictive qualities of opioids with them.
In 2019, health care providers dispensed more than 153 million opioid prescriptions, according to the Centers for Disease Control and Prevention. According to a recent study, an estimated 1 percent to 4 percent of patients who are prescribed opioids develop opioid use disorder.
U.S. Reps. Teresa Leger Fernandez (D-NM), David McKinley (R-WV), Guy Reschenthaler (R-PA), and David Trone (D-MD) introduced the bill.
The bill has the support of numerous organizations, including Voices for Non-Opioid Choices.
“We applaud Reps. Trone, McKinley, Leger Fernández, and Reschenthaler for introducing The Opioids Patients’ Right to Know Act, which will help to ensure patients and providers are educated about opioids and learn about the non-opioid treatment options that may be available to them,” Chris Fox, Voices for Non-Opioid Choices executive director, said. “We are hopeful this effort will help reduce the rates of chronic opioid use after surgery in America and provide greater access to non-opioid options.”